Decrease in reduced glutathione and NADPH and inhibition of glucose-6-phosphate dehydrogenase activity caused by metabolites of fluroxene and halothane.
D000079:Acetaldehyde / Q000494:pharmacology*; D000085:Acetates / Q000494:pharmacology*; D000818:Animals; D002247:Carbon Isotopes; D002849:Chromatography, Gas; D003864:Depression, Chemical; D004912:Erythrocytes / Q000187:drug effects; D000431:Ethanol / Q000097:blood / Q000494:pharmacology*; D005461:Fluorine / Q000097:blood; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors*; D005978:Glutathione / Q000037:antagonists & inhibitors*; D006207:Half-Life; D006221:Halothane / Q000494:pharmacology*; D009249:NADP / Q000037:antagonists & inhibitors*; D051381:Rats; D013053:Spectrophotometry
D000085:Acetates; D002247:Carbon Isotopes; D005461:Fluorine; D000431:Ethanol; D009249:NADP; D005954:Glucosephosphate Dehydrogenase; D005978:Glutathione; D000079:Acetaldehyde; D006221:Halothane